Player size: small large

ISHLTv_04 - The Evolving Science of Shock Recognition and Management

Jul 22, 2020 3:00pm ‐ Jul 22, 2020 4:30pm

Members: Free

Overview
Comments

An ISHLT 2020 Symposium Presentation

Session Description:
This session aims to review the evolving understanding of cardiogenic shock, including its varied presentations and trajectories, the importance of hemodynamic data in management, determination of treatment options, and the rapidly growing concept of multidisciplinary shock teams to deliver expedited and patient-centered care.

Scientific Program Agenda:

Moderators:
Shelley Hall, MD, FACC, FHFSA, FAST, Baylor University Medical Center, Dallas, TX, USA
Peter MacDonald, MD, PhD, St. Vincent’s Hospital, Sydney, Australia

Welcome, Symposium Overview
Kiran K. Khush, MD, Stanford University, Stanford, CA, USA
Liaison, ISHLT 2020 Program Committee Heart Group

Program Introduction
Moderators

From Code STEMI to Code Shock: Early Recognition is Key
Anique Ducharme, MD, MSc, Montreal Heart Institute, Montreal, QC, Canada

This talk will review the various phenotypes of cardiogenic shock and the new proposed shock categorization system. The importance of hemodynamics in shock recognition and treatment decision making will also be covered.

Let the Tissue Breathe: Use of Biomarkers to Optimize Organ Perfusion
Sandra Chaparro, MD, FACC, Miami Cardiac and Vascular Institute, Baptist Health South Florida, Miami, FL, USA

This talk reviews the best way to guide shock management from the blood-based biomarker point of view, in order to guide resuscitation strategies. This will include discussion of the comprehensive metabolic panel, lactate, troponin, and venous blood gas.

Drug Therapy for Cardiogenic Shock: Which, When, and How
Douglas Greig, MD, Pontificia Universidad Catolica de Chile, Santiago, Chile

The evidence for medical therapies as the initial basis for management of cardiogenic shock will be presented.

Teamwork Makes the Dream Work: Evolution of the Shock Team
Sharon Chih, MBBS, PhD, University of Ottawa Heart Institute, Ottawa, ON, Canada

This talk will discuss the development of shock teams, the structure of various programs, and their efficacy. The speaker will review tips and recommendations for best practices. How to choose the proper device for support within the shock team collaborative concept will also be covered.

Q & A segment with All Speakers
Led by Moderators

ISHLT Advanced Heart Failure and Transplantation Interdisciplinary Network Update
Marta Farrero Torres, MD, PhD, Hospital Clinic de Barcelona, Barcelona, Spain
Chair, Advanced Heart Failure and Transplantation Interdisciplinary Network Steering Committee

ISHLT Announcements
Greg Schultz, CEO, ISHLT, Addison, TX, USA

Speaker(s):

Shelley Hall, MD, FACC, FHFSA, FAST, Chief of Transplant Cardiology and Mechanical Support/Heart Failure, Baylor University Medical Center, Dallas, TX, USA
Peter Macdonald, MBBS, FRACP, PhD, MD, Conjoint Professor of Medicine, University of New South Wales, Senior Staff Cardiologist; Cardiopulmonary Transplant Unit, Co-Head of the Transplantation Research Laboratory, Victor Chang Cardiac Research Institute, St. Vincent's Hospital, Sydney, Australia
Kiran Khush, MD, MAS, Associate Professor of Cardiovascular Medicine, Stanford University Medical Center, Stanford, CA, USA
Anique Ducharme, MD, MSc, Director, Heart Failure Clinic, Montreal Heart Institute, Montreal, QC, Canada
Sandra Chaparro, MD, FACC, Miami, FL, USA, Baptist Health South Florida, Florida International University
Douglas Greig, MD, Associate Professor and Heart Failure Specialist, Pontificia Universidad Catolica de Chile Universitary Hospital, Santiago, Chile
Sharon Chih, MBBS, PhD, Cardiologist, Assistant Professor, University of Ottawa, University of Ottawa Heart Institute, Ottawa, ON, Canada
Marta Farrero Torres, MD, PhD, Barcelona, Spain, Hospital Clinic de Barcelona
Greg Schultz, CEO, Addison, TX, USA, International Society for Heart and Lung Transplantation

You must be logged in and own this session in order to post comments.